The study on the development of precise assays for human hemoglobin

人血红蛋白精密检测方法的开发研究

基本信息

  • 批准号:
    02671071
  • 负责人:
  • 金额:
    $ 0.77万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1990
  • 资助国家:
    日本
  • 起止时间:
    1990 至 1991
  • 项目状态:
    已结题

项目摘要

The present study was undertaken to establish clinical usefulness of urinary hemoglobin under pathlogic conditions. Hemoglobin (Hb) was purified from erythrocytes and its rabbit antibody was thus prepared. Using purified Hb as standard and rabbit antibody, a manual latex agglutination test and a radioimmunoassay of a double antibody system were established. Based on previous experiences, Hb was obtained by isoelectric focusing : hemolysate was at first obtained by hemolyzing with distilled water containing a equal volume of toluene. Hb rich fractions were thus separated on isoelectricfocusing under pH 6-8 and sucrose density gradient from 5 t6 50%. A highest peak from PH 7.02-7.08 was collected and used as standard and immunogen. Rabbit antibody was prepared according to established methods previously reported.A latex agglutination test was thus established in the same manner as previously reported. There was no positive reaction in 14 normal urine. In evaluating pathologic urine, the result by the test showed a good coincidence with that by a dipstick test. Provided urine osmolarity was low, the present test could more sensitively detect minute amounts of Hb. The merit of the test based on antigen-antibody reaction was that it can detect Hb without interference of ascorbic acid and myoglobin.Since the variation of microhemoglobulinuria may be of clinical significance, a double antibody radioimmunoassay was establised. The assay was quite sensitive to detect about 10 ng/ml of Hb and intra-assay precision in purified Hb was satisfactory. however, precision, recovery and a dilution test were all poor in evaluating urinary Hb. This was explained by generation of methohemoglobin upon exposure to air. A further study is needed to prevent Hb from being degenerated.
本研究旨在确定病理条件下尿血红蛋白的临床应用价值。从红细胞中提纯血红蛋白(Hb),制备了Hb的兔抗体。以纯化血红蛋白为标准品,用兔抗建立了乳胶凝集法和双抗体放射免疫分析法。根据以前的经验,Hb是通过等电聚焦获得的:首先通过用含有等体积甲苯的蒸馏水溶血获得溶血产物。因此,在pH 6-8和5至650%的蔗糖密度梯度下,等电聚焦分离富含Hb的组分。收集pH 7.02-7.08的最高峰,并用作标准品和免疫原。按已建立的方法制备兔抗体,建立乳胶凝集试验。14例正常人尿液中均无阳性反应。在评价病理性尿时,本试验与试纸条试验的结果有较好的一致性。如果尿渗透压较低,本试验可以更灵敏地检测微量Hb。本试验以抗原抗体反应为基础,其优点是不受抗坏血酸和肌红蛋白的干扰,可测定Hb,尿微量血红蛋白的变化可能有临床意义,因此建立了双抗体放射免疫分析法。该方法对10 ng/ml左右的血红蛋白具有很高的灵敏度,对纯化的血红蛋白具有良好的批内精密度。但精密度、回收率和稀释试验均较差。这是通过暴露于空气后生成甲氧血红蛋白来解释的。防止血红蛋白变性需要进一步研究。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Y. Itoh et al.: "A fundamental study on a radioimmunoassay for urinary hemoglobin AO."
Y. Itoh 等人:“尿血红蛋白 AO 放射免疫测定的基础研究。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
伊藤 喜之: "尿中ヘモグロビンA_0のRadioimmund assay法の開発と基礎的研究"
伊藤义之:“尿血红蛋白A_0放射免疫测定方法的发展与基础研究”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
佐藤 喜久: "尿中ヘモグロビンA_0のRadisimmunoassay法の開発と基礎的研究"
佐藤佳久:“尿血红蛋白A_0放射免疫测定方法的发展及基础研究”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y.Itoh: "Development of a manual latex agglutination test for urinary hemoglobin"
Y.Itoh:“尿血红蛋白手动乳胶凝集试验的开发”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y. Itoh et al.: "Development of a manual latex agglutination test for urinary hemoglobin"
Y. Itoh 等人:“尿血红蛋白手动乳胶凝集试验的开发”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ITOH Yoshihisa其他文献

ITOH Yoshihisa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ITOH Yoshihisa', 18)}}的其他基金

Elucidation of heterogeneity of urine proteins as fundamentals for analyses of pathophysiology
阐明尿蛋白的异质性作为病理生理学分析的基础
  • 批准号:
    18590519
  • 财政年份:
    2006
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Gene Polymorphism of Urine Protein 1 and its Clinical Application.
尿蛋白1基因多态性及其临床应用。
  • 批准号:
    14370791
  • 财政年份:
    2002
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Laboratory Investigation on Protein 1/ Clara Cell 10 kDa Protein
蛋白质 1/Clara 细胞 10 kDa 蛋白质的实验室研究
  • 批准号:
    11672302
  • 财政年份:
    1999
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Localization, function and clinical significance of semen-related proteins
精液相关蛋白的定位、功能及临床意义
  • 批准号:
    08672648
  • 财政年份:
    1996
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Stability of beta_2-microglobulin in urine
尿液中β_2-微球蛋白的稳定性
  • 批准号:
    04671439
  • 财政年份:
    1992
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Clinical Application of Human alpha_1-T Glycoprotein
人α_1-T糖蛋白的临床应用
  • 批准号:
    62571037
  • 财政年份:
    1987
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

human urine-derived stem cellsを用いた非翻訳領域における病的変化の解明
使用人尿干细胞阐明非翻译区域的病理变化
  • 批准号:
    24K18879
  • 财政年份:
    2024
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
用尿液检测代替侵入性膀胱镜检查进行非肌肉侵入性膀胱癌监测
  • 批准号:
    10559724
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
Clinical applications of urine proteomics to lupus nephritis
尿液蛋白质组学在狼疮性肾炎中的临床应用
  • 批准号:
    10567630
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
A Development of Fully Automated Artificial Intelligence System for Urine Cytology
尿细胞学全自动人工智能系统的开发
  • 批准号:
    23K08783
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel Urine Sample Collection and Transportation Medical Device Suitable for Measuring the Vaginal Microbiome using Next Generation Sequencing (NGS)
适合使用下一代测序 (NGS) 测量阴道微生物组的新型尿液样本采集和运输医疗设备
  • 批准号:
    10076109
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Collaborative R&D
Impact of preanalytic procurement and processing variables on the detection of HCC DNA in urine
分析前采购和处理变量对尿液中 HCC DNA 检测的影响
  • 批准号:
    10549981
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
High efficiency extraction of urine cell-free DNA by transient isotachophoresis and fragmentomics analysis
通过瞬时等速电泳和片段组学分析高效提取尿液游离 DNA
  • 批准号:
    23H03769
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
SBIR Phase II: Development of a urine dipstick test that can guide immediate and appropriate antibiotic therapy for treatment of complicated urinary tract infections
SBIR II 期:开发尿液试纸测试,可以指导复杂尿路感染的立即和适当的抗生素治疗
  • 批准号:
    2213034
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Cooperative Agreement
Temperature and time after urine collection affects the detection of phenethylamine, a doping prohibited-substance
尿液采集后的温度和时间影响兴奋剂违禁物质苯乙胺的检测
  • 批准号:
    23K10689
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Evaluation of Pre-Analytical Factors of Urine Samples for Urine Cancer Cell Cultures (UCCC) --A Non-Invasive Biomarker – in Monitoring Response and Recurrence of Bladder Cancer
尿癌细胞培养 (UCCC) 尿液样本分析前因素的评估——一种非侵入性生物标志物 — 用于监测膀胱癌的反​​应和复发
  • 批准号:
    10640606
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了